The molecular mechanism of C3 deficiency in an Afrikaans patient with recurrent pyogenic infections was studied. Restriction enzyme analysis showed a gene deletion of 800 base pairs (bp) mapping to the a chain of C3. Amplification of genomic DNA, using the PCR, demonstrated that the deletion included exons 22 and 23 of the C3 gene. Truncated mRNA was shown in an Epstein-Barr virus-transformed B-cell line by PCR amplification of first-strand cDNA. A consequence of this deletion was that the RNA transcribed 3' to the deletion was out of frame, resulting in formation of a stop codon 19 bp downstream from the deletion. The molecular basis of the deletion was compatible with homologous recombination between two Alu sequences located in introns 21 and 23. An unrelated nonconsanguineous relative and two of a sample of 174 Afrikaansspeaking individuals were heterozygous carriers of the same gene deletion. The wide prevalence of this null allele in this population is probably due to the effects of a small founder population. The presence of this deletion in the C3 gene is not compatible with production ofany functional C3, supporting the idea that study of such patients offers a valid model for understanding physiological activities of C3 in vivo in humans.
Analysis of patients with hereditary deficiencies of complement proteins has given insight into the physiological actions in vivo of the complement system in host defense against pyogenic infections and disease mediated by immune complexes. Complement protein C3 is the major protein of the complement system in plasma in terms of quantitative expression, at -1 g/liter. Cleavage of C3 by C3 convertase enzymes results in release of the anaphylatoxin C3a. The other product of the initial cleavage of C3, C3b, covalently fixed to surfaces, acts as a focus for formation of the C5 convertase enzyme and, together with its further cleavage product, iC3b, is a ligand for complement receptors CR1 and CR3. Absence of C3 is a rare condition in humans and provides the best opportunity for investigating the physiological activities of this protein in vivo in humans.
To date 15 patients, who suffered from recurrent pyogenic infections and/or rashes and nephritis (1-10), have been described with inherited homozygous C3 deficiency. Characterization of the full genomic organization of the human C3 gene (11) allowed us to identify a splice site mutation as the molecular basis for C3 deficiency in a 10-year-old English patient (12) . Data have also been reported on the biochemical basis of a genetically determined C3 deficiency in guinea pigs (13) . There is evidence for genetic heterogeneity in the molecular basis of C3 deficiency in humans as suggested by the presence of small amounts of circulating C3 in the sera of some patients (4) but not of others (14) .
In this paper, we report the molecular basis of C3 deficiency in an Afrikaans patient previously described by Alper and colleagues (1) as homozygous C3 deficient. By Southern blot analysis, we found that the structural alteration of the C3 null gene was an 800-base-pair (bp) deletion in the a chain including two coding regions (exons 22 and 23) . This leads to a disturbance of the reading frame of the C3 mRNA with a stop codon 19 bp downstream from the deletion. DNA sequence analysis revealed that the deletion probably arose from homologous recombination between two Alu repeats flanking the deletion, which resulted in generation of a recombined Alu element in the deletion sequence. This mutant allele was found to have a gene frequency of 0.0057 in the South African Afrikaans-speaking population. §
MATERIALS AND METHODS
Preparation and Analysis of Genomic DNA. Genomic DNA was isolated from whole blood of the patient, her family, and 174 Afrikaans-speaking white South Africans. DNA (10 jig) was digested to completion with two different restriction enzymes (EcoRI and Sst I) (GIBCO/Bethesda Research Laboratories) and transferred (15) to Hybond-N membranes (Amersham). The filters were hybridized with a cDNA probe for C3, pC3.11 (16) (kindly provided by G. Fey, Scripps Clinic, La Jolla, CA), which was labeled by the randomprimer method (17) , washed at high stringency (0.2x standard saline citrate/0.1% SDS at 65°C), and autoradiographed.
mRNA Extraction from B-Lymphoblastoid Cell Line.
Mononuclear cells were isolated from 40 ml of peripheral blood of the patient and her family by centrifugation on Lymphoprep (Nycomed, Oslo). B lymphocytes were separated and transformed by Epstein-Barr virus (EBV). EBVtransformed B-cell lines were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum in the presence or absence of lipopolysaccharide (5 ,ug/ml). mRNA was extracted by the guanidinium isothiocyanate/cesium chloride method (15) .
cDNA Synthesis and PCR Amplification. First-strand cDNA synthesis was performed as described (18) (1) and she was the first subject to be identified with homozygous C3 deficiency. She developed two episodes of meningococcal meningitis at 5 and 6 years of age. From the age of 6-18 years, she was admitted to hospital an average of two or three times each year with episodes of pneumonia. Each of these infections was followed by development of a self-limiting rash variously described as erythema gyratum perstans (1) and Sweet syndrome (20) . Skin biopsy has shown a dense dermal and subdermal neutrophilic infiltrate with leukocytoclasis (1). Since 1985, she has been entirely well and has had no further admissions to hospital and no episodes ofrash. She has given birth to three normal children, now 14, 10, and 7 years old. The patient's parents were first cousins, as were her paternal grandparents (21) .
Abnormal Structure of the C3 Nuil Gene. Genomic DNA from the patient and her family was analyzed by Southern blotting. An 800-bp deletion in the C3 null gene compared to the normal allele was found in the patient and her family after digestion with Sst I and EcoRI restriction enzymes. Fig. 1A shows that the normal 3.2-kilobase (kb) Sst I fragment was replaced by a 2.4-kb fragment in the patient, indicating a partial gene deletion of 800 bp. The presence of both the normal 3.2-kb and unique 2.4-kb Sst I fragments in the children ofthe propositus was consistent with heterozygosity for the partially deleted allele. In addition, EcoRI-digested DNA from the patient lacked a normal 5.6-kb band, which was replaced by a larger band of 17 kb (Fig. 1A) , generated by the loss of an EcoRI restriction site from the coding region of exon 23 (11) . These findings allowed us to map the 800-bp deletion to a region of the a chain spanning exon 20 (first Sst I site at nucleotide 2639) to exon 24 (second Sst I site at nucleotide 3203) (16) (Fig. 1B) . We then used two approaches, one at the mRNA level and one at the genomic level, in order to define the detailed structure of the deletion.
Sequence Analysis of the Abnormal C3 cDNA. First-strand cDNA synthesis was performed with mRNA extracted from EBV-transformed cell lines as a template. Segments of this were amplified by PCR using target sequences encoding different regions of the C3 molecule. Amplification of the region spanning exons 20-24 (using oligonucleotides EX20 and EX24 as primers) from the patient generated a product that was 154 bp smaller than that found in the normal subject (Fig. 2) . Both the normal and the short PCR products were detected from the cDNA of the patient's children (data not shown), who were heterozygous for the deletion (Fig. 1A) . Amplification of two other regions of the cDNA 5' and 3' to the deletion (spanning exons 3-7 in the ,B chain and exons 28-30 in the a chain) generated products ofidentical size from both the patient and a normal subject (Fig. 2) .
The abnormal cDNA fragment from the patient was sequenced and a 154-bp deletion was found (from nucleotides their phases [respectively, type 0 (interrupting two exons between codons) and type 1 (interrupting two exons after the first nucleotide of a codon)] (Fig. 1B) , the resulting mRNA was out of the normal translation frame distal to the deletion generating a stop codon (TGA) 19 bp downstream of the 5' end of exon 24 (Fig. 3) .
Junctions of the Genomic Deletion. Genomic DNA spanning exons 21-24 from the patient and a normal subject were amplified by PCR in order to localize precisely the breakpoints of the deletion. PCR products of 2.8 and 2 kb, respectively, were generated from normal and from patient DNA (Fig. 4) . Amplified fragments were mapped by single and double digests and sequenced, after subcloning into M13mpl8 and M13mpl9. The sequence of normal genomic DNA showed the presence of two Alu sequences, one located in intron 21 and one in intron 23. These were oriented in the opposite direction with respect to the C3 gene.
The sequence of the mutant allele showed the deletion of exons 22 and 23, and the structure of the intron between exons 21 and 24 was a hybrid between the normal intron 21 and 23 sequence. The sequence of this intron changed from that of normal intron 21 to that of normal intron 23 within the two Alu sequences (Fig. 5) . Comparison of the sequences suggests that the mutant sequence may have arisen by homologous recombination between the two Alu sequences within a region of 19 nucleotides, located in the left arm of the Alu repeat between the A and B promoter sites of RNA polymerase III. Therefore, the deletion event has resulted in a reconstituted Alu sequence (Fig. 5) (22) .
Frequency of the C3 Null Gene in the Afrikaner Population of South Africa. It was noted, as part of the original family study of the propositi, that there was a nonconsanguineous relative of the patient who had heterozygous deficiency of C3 (21) . We obtained a blood sample from this individual and showed that she was also heterozygous for the identical C3 gene deletion. We then went on to ascertain the prevalence of the deleted allele in a consecutive series of 174 Afrikaansspeaking white South Africans attending a casualty department (with informed consent and permission of the local research ethics committee). Southern blot analysis was performed using the Sst I restriction enzyme. The same gene deletion was identified in two of these individuals, giving a gene frequency of 0.0057. These individuals expressed C3 (6) . The Afrikaners are a distinctive population of white South Africans whose ancestry has been traced to a small group of Dutch, German, and Huguenot settlers who founded the Cape Colony in the late 17th and early 18th centuries (33) . They form a relatively inbred community as a result of past breeding patterns and have an unusually high prevalence of certain rare inherited diseases. These include familial hypercholesterolemia, porphyria variegata, progressive familial heart block, sclerosteosis, lipoid proteinosis, and Huntington chorea (33, 34) . A combination of the founder effect, intermarriage, and genetic drift is likely to be the explanation for this high prevalence ofcertain inherited diseases. The present findings add another member to the unique pattern of genetic disorders prevalent among the Afrikaans population of South Africa. C3 deficiency has also been described in a Dutch family (8) , and we wondered if this might be due to the same mutation. However, our initial investigations on a C3 deficiency member of this Dutch family did not show the same deletion found in the South African patient (data not shown).
In conclusion, we have identified a small genomic deletion as the cause of homozygous C3 deficiency in an Afrikaans patient. This probably arose because of homologous recombination in which unequal crossing-over resulted from mispairing of homologous Alu sequences during meiosis. This abnormal gene has achieved a relatively high frequency in the Afrikaner population of South Africa, probably through the founder effect mechanism.
